OT Pharma Fund III, LLC
Ot · adviser of record: OT Management, LLC · 2019 vintage
OT Pharma Fund III, LLC is a 2019 venture fund managed by Ot, with $24.5mm raised (Form D, amount sold). It reported $10.9mm in gross assets at year-end 2025, 0.45x its size, its highest reported value.
- Latest value held
- $10.9mm year-end 2025
- Peak
- $10.9mm year-end 2025
- Fund size
- $24.5mm Form D, amount sold
- Held vs. size
- 0.45x peak 0.45x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $10.9mm | 0.45x | +109% over 2 yrs |
| 2023 | $5.2mm | 0.21x | -37% |
| 2022 | $8.3mm | 0.34x | -0% |
| 2021 | $8.3mm | 0.34x | – |
Other funds from Ot
- OT Pharma Fund VIII, LLC 2023
- OT EM Fintech Fund I, LLC 2022
- OT MBC Fund I, LLC 2022
- OT Dapper Fund I, LP 2021
- Zola Global Investors I, LLC 2021
- OT Asia Fintech Fund I, LLC 2021
- OT Bioag Fund III, LLC 2021
- Zola Ventures Fund I, LLC 2021
- QLT Holdings, LLC 2021
- OT Pharma Fund VII, LLC 2021
- Otgc Fintech Fund I, LLC 2021
- OT Hsa Fund I, LLC 2021
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-7543894356. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.